StockWatch
·

Avalo Therapeutics, Inc.

Ticker: 1534120

values in millions

Revenue & Profit Trend

in millions
RevenueExpenditureNet Profit
-14.91-0.6113.6927.99Q1 FY2023Q1 FY2023Q1 FY2023Q2 FY2023Q2 FY2023Q3 FY2023Q3 FY2024Q3 FY2024

Margin Trend

percentage
OPM %NPM %
-130.00-43.3343.33130.00Q1 FY2023Q1 FY2023Q1 FY2023Q2 FY2023Q2 FY2023Q3 FY2023Q3 FY2024Q3 FY2024
PeriodQ3 FY2024Q3 FY2024Q3 FY2023Q2 FY2023Q2 FY2023Q1 FY2023Q1 FY2023Q1 FY2023
INCOME
Revenue0.25+0.0%0.25+4.2%0.24-62.5%0.64+0.0%0.64+33.3%0.48+0.0%0.48+0.0%0.48
Total Income0.25+0.0%0.25+4.2%0.24-62.5%0.64+0.0%0.64+33.3%0.48+0.0%0.48+0.0%0.48
EXPENSES
Expenditure13.11+0.0%13.11+228.6%3.99-48.8%7.79+0.0%7.79-16.0%9.27+0.0%9.27+0.0%9.27
Tax-0.01+0.0%-0.01-200.0%0.01+0.0%0.01+0.0%0.01+0.0%0.01+0.0%0.01+0.0%0.01
PROFIT
PBT23.02+0.0%23.02+541.0%-5.22+36.3%-8.19+0.0%-8.19+17.7%-9.95+0.0%-9.95+0.0%-9.95
Net Profit23.04+0.0%23.04+540.5%-5.23+36.1%-8.19+0.0%-8.19+17.8%-9.96+0.0%-9.96+0.0%-9.96
KEY METRICS
OPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
NPM %100.00%100.00%+200.00pp-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
EPS0.98+0.0%0.98+990.9%-0.11+81.4%-0.59+99.6%-140.73+31.0%-204.00+0.0%-204.00-23900.0%-0.85